Amalia M. Issa, PhD, MPH, a leader in the field of personalized medicine and translational research, has joined University of the Sciences as professor and chair of the Department of Health Policy and Public Health in the University’s Mayes College of Healthcare Business and Policy.
Dr. Issa is the founding director of the Program in Personalized Medicine & Targeted Therapeutics and is bringing her research program to USciences. Since 1998, she has developed a unique area of translational research focused on pharmacogenomics and personalized medicine applications, and how they will be translated and integrated into health care delivery and health systems. Dr. Issa’s previous appointment was as associate professor in the College of Pharmacy at the University of Houston.
A frequent invited speaker at national and international conferences, Dr. Issa has numerous publications in her field and serves as a reviewer for several scientific journals and granting agencies. In addition, she sits on editorial boards for Personalized Medicine and Expert Review of Clinical Pharmacology. She has served or is serving as the principal investigator on a number of funded projects, and in leadership positions in several national and international professional associations, including the International Society for Pharmacoepidemiology, the American College of Clinical Pharmacology, and as a Pharmacogenomics Advisory Group member of the Coriell Institute. Dr. Issa has received many awards and honors for her work.
A native of Montreal, Quebec, Canada, Dr. Issa holds degrees from Concordia University (bachelor of science in biology), McGill University ( MSc and PhD in neuropharmacology from the Department of Neurology and Neurosurgery), and the UCLA School of Public Health (MPH), and completed a fellowship at Harvard Medical School.